home / stock / bway / bway news

BWAY News and Press, BrainsWay Ltd. From 05/24/21

Stock Information
Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com
Menu
BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...
BWAY - BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS(TM)

CRESSKILL, N.J. and JERUSALEM, May 24, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Centene ...
BWAY - BrainsWay Ltd. (BWAY) CEO Chris von Jako on Q1 2021 Results - Earnings Call Transcript

BrainsWay Ltd. (BWAY) Q1 2021 Earnings Conference Call May 20, 2021 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Chris von Jako - President & Chief Executive Officer Scott Areglado - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jeffre...

BWAY - Brainsway EPS misses by $0.03, beats on revenue

Brainsway (BWAY): Q1 GAAP EPS of -$0.11 misses by $0.03.Revenue of $6.1M (+46.6% Y/Y) beats by $0.29M.Press Release For further details see: Brainsway EPS misses by $0.03, beats on revenue

BWAY - BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights

Strong Revenue Growth of 47% Year-over-Year in Q1 2021 Successfully Executed Initial U.S. Controlled Market Release of Deep TMS for Smoking Addiction Strengthened Balance Sheet Through Successful Equity Offering; Ended Q1 2021 with $58.5 Million in Cash Conferenc...
BWAY - BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

CRESSKILL, N.J. and JERUSALEM, May 19, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced that Christopher von Jako, Ph.D., Pr...

BWAY - BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021

CRESSKILL, N.J. and JERUSALEM, Israel, May 06, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced that it will report its firs...

BWAY - BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer

CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointme...
BWAY - BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month

CRESSKILL, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd . (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the launch of its nationwide Sweepstakes,...

BWAY - BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month

CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the Comp...

BWAY - BrainsWay launches noninvasive treatment for smoking addiction

BrainsWay (BWAY) announces the distribution of its first 10 Deep Transcranial Magnetic Stimulation ((Deep TMS)) devices for smoking addiction to practices across the United States.Deep TMS is the first FDA-cleared noninvasive treatment in the addiction space for any TMS device, and ...
Previous 10 Next 10